Beyond the full-length toxin: The metalloprotease domain of Pictolysin-III retains key functional properties and cellular activity

Snake venom metalloproteinases are major determinants of viperid venom pathology, but the specific contribution of their metalloprotease domain to toxin function remains insufficiently defined. Here, we produced and characterized the metalloprotease domain of Pictolysin-III, a P-III metalloproteinase from Bothrops pictus, using two heterologous expression systems: Pichia pastoris KM71H and Escherichia coli BL21 Star™ (DE3). Codon-optimized constructs containing the prodomain, an N-terminal His-tag, and a TEV cleavage site were generated, sequence-verified, expressed, purified by Ni-NTA chromatography, and activated by TEV processing. Both recombinant proteins were immunoreactive and catalytically active but showed host-dependent biochemical and biological profiles. The P. pastoris-derived protein, rMD-Pp, displayed a higher apparent molecular mass and greater final recovery than the E. coli-derived protein, rMD-Ec. Relative to native Pictolysin-III, rMD-Pp retained 59.44 ± 0.56% azocaseinolytic activity, whereas rMD-Ec retained 23.49 ± 0.79%. rMD-Pp also showed functional preservation under acidic conditions, fibrino(geno)lytic activity, and hemorrhagic activity. In contrast, rMD-Ec showed reduced proteolytic performance and no visible hemorrhagic lesion at the tested doses up to 4 µg. Exploratory molecular dynamics simulations of theoretical glycosylated and non-glycosylated models suggested comparable global compactness, with higher calculated solvent exposure and localized flexibility, particularly around the omega-loop region. Real-time cell analysis showed distinct cell-line-dependent impedance profiles in RMF-621, MCF-7, and MDA-MB-231 cells. Overall, these findings demonstrate that the metalloprotease domain constitutes an active functional unit of Pictolysin-III. However, the two recombinant preparations differed in their biochemical and biological profiles, with rMD-Pp more closely reproducing the functional properties of the native toxin than rMD-Ec.

Authors

Institutions

Publication Details

Journal
Biomedicine & Pharmacotherapy
Published
2026-08-14
DOI
https://doi.org/10.1016/j.biopha.2026.119854
Primary Topic
Venomous Animal Envenomation and Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beyond the full-length toxin: The metalloprotease domain of Pictolysin-III retains key functional properties and cellular activity

Daniel Torrejón, Álex Proleón, Juan Cabrejos, Félix A. Urra et al.
Biomedicine & Pharmacotherapy
Venomous Animal Envenomation and Studies
article

Beyond the full-length toxin: The metalloprotease domain of Pictolysin-III retains key functional properties and cellular activity

Daniel Torrejón, Álex Proleón, Juan Cabrejos, Félix A. Urra, Fanny Lazo, Víctor Otárola, Cristopher Almarza, Armando Yarlequé, Dan E. Vivas-Ruiz, Edith Rodríguez, Alejandro Roque, Ignacio Contreras Saá, Luciana Souza Oliveira, Tania Broncano
article en

Abstract

Snake venom metalloproteinases are major determinants of viperid venom pathology, but the specific contribution of their metalloprotease domain to toxin function remains insufficiently defined. Here, we produced and characterized the metalloprotease domain of Pictolysin-III, a P-III metalloproteinase from Bothrops pictus, using two heterologous expression systems: Pichia pastoris KM71H and Escherichia coli BL21 Star™ (DE3). Codon-optimized constructs containing the prodomain, an N-terminal His-tag, and a TEV cleavage site were generated, sequence-verified, expressed, purified by Ni-NTA chromatography, and activated by TEV processing. Both recombinant proteins were immunoreactive and catalytically active but showed host-dependent biochemical and biological profiles. The P. pastoris-derived protein, rMD-Pp, displayed a higher apparent molecular mass and greater final recovery than the E. coli-derived protein, rMD-Ec. Relative to native Pictolysin-III, rMD-Pp retained 59.44 ± 0.56% azocaseinolytic activity, whereas rMD-Ec retained 23.49 ± 0.79%. rMD-Pp also showed functional preservation under acidic conditions, fibrino(geno)lytic activity, and hemorrhagic activity. In contrast, rMD-Ec showed reduced proteolytic performance and no visible hemorrhagic lesion at the tested doses up to 4 µg. Exploratory molecular dynamics simulations of theoretical glycosylated and non-glycosylated models suggested comparable global compactness, with higher calculated solvent exposure and localized flexibility, particularly around the omega-loop region. Real-time cell analysis showed distinct cell-line-dependent impedance profiles in RMF-621, MCF-7, and MDA-MB-231 cells. Overall, these findings demonstrate that the metalloprotease domain constitutes an active functional unit of Pictolysin-III. However, the two recombinant preparations differed in their biochemical and biological profiles, with rMD-Pp more closely reproducing the functional properties of the native toxin than rMD-Ec.

Biomedicine & PharmacotherapyVol. 203
National University of San Marcos (PE), Ezequiel Dias Foundation (BR), Instituto de Neurociencia Biomédica (CL)
Universidad Nacional Mayor de San Marcos, Agencia Nacional de Investigación y Desarrollo
Life in Land
Openalex Percentile: Top 10%
Venomous Animal Envenomation and Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.